ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea
· Delayed Price · Currency is KRW 7,680.00
+80.00 (1.05%)
At close: Mar 6, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 569.59 billion as of March 9, 2026.
Market Cap
569.59B
Enterprise Value
538.01B
Revenue
715.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
7,680.00
Market Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has increased from 547.53B to 569.59B, an increase of 4.03%. That is a compound annual growth rate of 5.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 542.15B | -43.86% |
| Dec 30, 2025 | 965.63B | 76.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 535.01B |
| Samyang Biopharm | 689.31B |
| CellBion | 359.28B |
| Myung In Pharmaceutical LTD. | 905.20B |
| DAE HWA Pharmaceutical | 250.31B |
| NOVAREX | 225.53B |
| Vivozon Pharmaceutical | 196.71B |
| G2GBIO | 1,697.89B |